Stephen Chi Wai Cheung

Stephen Chi Wai Cheung

Auto-generated profile, based on publicly available information

Stephen Chi Wai Cheung

Department of Radiology, Queen Mary Hospital, Hong Kong, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
SPSoomin Park
Soomin Park
CCChi Wai Stephen Cheung
Chi Wai Stephen Cheung
VRVimal Raj
Vimal Raj
MIMasaki Ishida
Masaki Ishida
TTTarinee Tangcharoen
Tarinee Tangcharoen
SCSuyon Chang
Suyon Chang
Park S, et al. Korean J Radiol. 2025 Dec;26(12):1149-1156. https://doi.org/10.3348/kjr.2025.1214

1 January 2026 in Cardiovascular Imaging Asia
Verified
Journal Article
Open access
PLPak Lun Lam
Pak Lun Lam
CWChristie Ho Ting Wong
Christie Ho Ting Wong
SLSonia Hiu Yin Lam
Sonia Hiu Yin Lam
TYThomas Wei Lam Yip
Thomas Wei Lam Yip
YMYuen Hei Mak
Yuen Hei Mak
SCStephen Chi Wai Cheung
Stephen Chi Wai Cheung

1 January 2022 in Cardiovascular Imaging Asia
Verified
Journal Article
Open access
PDF file
WPWilliam Wai Lun Poon
William Wai Lun Poon
SCStephen Chi Wai Cheung
Stephen Chi Wai Cheung
CCCarmen Wing Sze Chan
Carmen Wing Sze Chan

1 January 2022 in Cardiovascular Imaging Asia
Verified
Journal Article
Open access
PNPan Pan Ng
Pan Pan Ng
BCBoris Chun Kei Chow
Boris Chun Kei Chow
SCStephen Chi Wai Cheung
Stephen Chi Wai Cheung
MNMing Yen Ng
Ming Yen Ng

16 October 2026 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
LHLam Kwok Ho
Lam Kwok Ho
SHSin Tsun Hei
Sin Tsun Hei
HYHo Shui Yan
Ho Shui Yan
IYIp Niki Hiu Yee
Ip Niki Hiu Yee
NCNg Wing Kei Carol
Ng Wing Kei Carol
NMNg Ming-Yen
Ng Ming-Yen
Coronavirus disease 2019 (COVID-19) has been associated with subclinical myocardial inflammation. Post-COVID-19 infection, there are concerns about subsequent heart failure and persistent myocarditis. It is unknown how COVID-19 infection compares with non-COVID-19 viral infections in terms of myocardial inflammation based on cardiovascular magnetic resonance (CMR) assessment. This prospective longitudinal study aims to determine and compare the extent and severity of myocardial involvement in patients with COVID-19 infection versus non-COVID-19 viral respiratory infections (control). Recruited recovered COVID-19 (RCOVID) patients and recovered non-COVID (non-COVID) patients from several hospitals and COVID-19-designated clinic underwent three CMR examinations for functional assessment, native T1, T2, and extracellular volume (ECV) quantification, with corroborating blood markers (NT-proBNP, white cell count, c-reactive protein, lactate dehydrogenase, and high sensitivity cardiac troponin T). CMR scans took place (i) within 2-week of confirmed recovery, (ii) 3-month, and (iii) 12-month post-recovery. Linear mixed model with Bonferroni correction was used for analysis. 152 participants were recruited, 112 RCOVID outpatients (mean age: 41.0; 58.9% female) and 40 non-COVID inpatients (mean age:45.0; 37.5% female). Non-COVID infections included influenza virus, rhinovirus/enterovirus, parainfluenza virus, respiratory syncytial virus, and human metapneumovirus. At all three time points, blood results and cardiac function parameters were not significantly different between RCOVID and non-COVID patient groups (p-value not significant). Both patient groups had no significant differences for native T1/T2 values, ECV, late gadolinium enhancement, T2 short tau inversion recovery, and overall fulfilment of the 2018 revised Lake Louise Criteria at each time points. In this prospective longitudinal study with CMR examinations, COVID-19 infection does not cause a worse myocardial inflammatory response than non-COVID-19 viral respiratory infection in terms of CMR parameters, and blood markers. During the coronavirus disease 2019 (COVID-19) outbreaks, some COVID-19 patients were incidentally found to have inflammation of the muscular layer of the heart. Healthcare professionals were concerned the inflammation will lead to heart not delivering enough blood to meet body demands (ie. heart failure) in the long run. Therefore, we designed this study to better understand the extent and severity of cardiac involvement in patients with COVID-19 by comparing them to patients with other types of viral respiratory infections, such as influenza, which we were more familiar with. We recruited two groups of patients, one group with patients recovered from COVID-19, the other group with patients recovered from other types of viral respiratory infections. For each patient, we arranged three assessments at 2 weeks, 3 months, and 12 months after their recovery respectively. During each assessment, they had blood taken and underwent a cardiovascular magnetic resonance (CMR) scan, a type of medical imaging used for assessment of heart function. 2018 revised Lake Louise Criteria (LLC) is a set of criteria for diagnosis of myocardial inflammation recommended by a group of experts. We compared the two groups of patients at each time point according to LLC, as well as their blood markers and heart function. In our study, we found that COVID-19 infection does not cause a worse heart muscle inflammatory response than other types of viral respiratory infections. This is reassuring as patients with previous COVID-19 infections will likely not develop inflammation of the heart muscle nor develop heart failure.

6 August 2025 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
SYSze Jin Adrian Yu
Sze Jin Adrian Yu
CCChi Wai Stephen Cheung
Chi Wai Stephen Cheung
MNMing Yen Ng
Ming Yen Ng